Jinhai Huo, PhD, MD, MPH; David R. Lairson, PhD; Xianglin L. Du, MD, PhD; Wenyaw Chan, PhD; Thomas A. Buchholz, MD; and B. Ashleigh Guadagnolo, MD, MPH
Hospice care is associated with improved median survival time for the patients diagnosed with metastatic melanoma, accompanied by decreased end-of-life costs.
Charles H. Hennekens, MD; Marc A. Pfeffer, MD; John W. Newcomer, MD; Paul S. Jellinger, MD, MACE; and Alan Garber, MD, PhD
The pandemic of type 2 diabetes mellitus requires implementation of multifactorial interventions by clinicians for individual
patients and policy makers for the health of the general public.
Erica L. Stockbridge, MA; Lindsey M. Philpot, PhD, MPH; and José A. Pagán, PhD
Analysis of the impact of individual features of the patient-centered medical home care model on future healthcare expenditures among Medicare beneficiaries.
Clifford Bleustein, MD, MBA; David B. Rothschild, BS; Andrew Valen, MHA; Eduardas Valaitis, PhD; Laura Schweitzer, MS; and Raleigh Jones, MD
Clinic wait times do not just affect overall patient satisfaction, but also specifically affect the perception of providers and the
quality of care.
Didem Minbay Bernard, PhD; Patrik Johansson, MD, MPH; and Zhengyi Fang, MS
Among nonelderly adults receiving hypertension treatment, 13.1% had high burdens, meaning that healthcare expenditures accounted for more than 20% of their income.
Dean F. Sittig, PhD; Joan S. Ash, PhD, MLS, MBA; and Hardeep Singh, MD, MPH
We describe the conceptual underpinnings of an EHR-related selfassessment strategy to provide institutions a foundation upon which they can build their safety efforts.
Paul G. Barnett, PhD; Adam Chow, BA; Vilija R. Joyce, MS; Ahmed M. Bayoumi, MD, MSc; Susan C. Griffin, MSc, BSc, PhD; Huiying Sun, PhD; Mark Holodniy, MD; Sheldon T. Brown, MD; D. William Cameron, MD; Mark Sculpher, PhD; Mike Youle, MB, ChB; Aslam H. Anis, PhD; and Douglas K. Owens, MD, MS
Antiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with
especially advanced HIV.
Manuela Casula, PhD; Alberico Luigi Catapano, PhD; Rossana Piccinelli, PharmD; Enrica Menditto, PhD; Lamberto Manzoli, MD, MPH; Luisa De Fendi, BSc; Valentina Orlando, PharmD; Maria Elena Flacco, MD; Marco Gambera, PharmD; Alessandro Filippi, MD; and Elena Tragni, PhD
This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.
Jesen Fagerness, JD; Eileen Fonseca, MS; Gregory P. Hess, MD, MBA, MSc; Rachel Scott, PharmD; Kathryn R. Gardner, MS; Michael Koffler, MBA; Maurizio Fava, MD; Roy H. Perlis, MD, MSc; Francis X. Brennan, PhD; and Jay Lombard, DO
Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.
Louise H. Anderson, PhD; Robin R. Whitebird, PhD, MSW; Jennifer Schultz, PhD; Charlene E. McEvoy, MD, MPH; Mary Jo Kreitzer, PhD, RN; and Cynthia R. Gross, PhD
Patients with an insomnia diagnosis have higher healthcare utilization and costs than a matched control group, both before and after the diagnosis.
Kevin J. Dombkowski, DrPH, MS; Lauren Costello, MSW; Shiming Dong, MS; and Sarah J. Clark, MPH
This study examines the feasibility and utility of using administrative claims from commercial health plans to identify children with chronic conditions in a statewide registry.